Therapy-related acute myeloid leukaemia following immunosuppression with azathioprine for polymyositis

Clin Lab Haematol. 1994 Sep;16(3):285-9. doi: 10.1111/j.1365-2257.1994.tb00422.x.

Abstract

A 52-year-old man developed therapy-related acute myeloid leukemia (AML) following prolonged immunosuppression with azathioprine for polymyositis. Karyotypic analysis showed deletions of the short arm of chromosome 7 and the long arm of chromosome 5. The importance of recognizing this potential complication while treating benign rheumatological and immunological diseases with purine analogues like azathioprine is emphasized. Therapy-related AML is a poor prognostic group that does not respond favourably to standard induction therapy.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Azathioprine / adverse effects*
  • Azathioprine / therapeutic use
  • Chromosome Deletion
  • Chromosomes, Human, Pair 5 / ultrastructure
  • Chromosomes, Human, Pair 7 / ultrastructure
  • Humans
  • Karyotyping
  • Leukemia, Myeloid / chemically induced*
  • Leukemia, Myeloid / genetics
  • Male
  • Middle Aged
  • Polymyositis / drug therapy*
  • Prognosis

Substances

  • Azathioprine